On scleroderma. Mast cells, endothelial cells, and fibroblasts

Area of Science:

• Immunology
• Pathogenesis of Scleroderma
• Fibrosis Research

Background:

• Scleroderma pathogenesis involves vascular, immunologic, and fibrotic processes.
• Mast cells are increasingly recognized for their role in autoimmune and fibrotic diseases.

Purpose of the Study:

• To integrate mast cells into the understanding of scleroderma pathogenesis.
• To highlight the role of mast cells in experimental chronic graft-vs-host disease and scleroderma.

Main Methods:

• Review of recent knowledge on mast cell activity in scleroderma models.
• Analysis of the link between mast cell activation, heparin-binding growth factors, endothelial cells, and fibroblasts.

Main Results:

• Increased mast cell activity observed in both experimental chronic graft-vs-host disease and scleroderma.
• Heparin-binding growth factors, potentially supplied by mast cells, may link endothelial cell and fibroblast activation.
• These growth factors may drive endothelial proliferation and excessive fibroblast collagen production.

Conclusions:

• Mast cells are a crucial component of the integrated scleroderma pathogenesis schema.
• Activated mast cells and associated growth factors present novel therapeutic targets for scleroderma intervention.